Frontlight ResearchEarly access
Sjögren's disease trials in Japan
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Where
- Fukuoka, Hiroshima, Hokkaido
- Age
- 18 years to 70 years
- People
- 44 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00 - Phase 3Taking peopleA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Where
- Chuo-ku, Hamamatsu, Iruma-Gun Moroyama-Machi, Kahoku, Kanazawa, Kita Kyushu-shi, Kurashiki-Shi, Kyoto, Meguro-Ku, Nagasaki, Nagoya, Nagoya-shi, Sapporo, Sasebo-Shi, Shinjuku-ku, tabashi City, Tsukuba, Yokohama
- Age
- 18 years and over
- People
- 844 worldwide
- Run by
- Amgen
See details and how to joinNCT06747949 · EU 2024-517513-32-00